What is CUSIP 81686G113?

CUSIP 81686G113 is the security identifier used in SEC filing datasets for SMNRW - Semnur Pharmaceuticals, Inc. - Common Stock, par value $0.0001.

Security Snapshot

Semnur Pharmaceuticals, Inc. - Common Stock, par value $0.0001 (SMNRW) Institutional Ownership

Q: Who owns SMNRW - Semnur Pharmaceuticals, Inc. - Common Stock, par value $0.0001 based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 81686G113

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.01

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / Common Stock, par value $0.0001
Symbol: SMNRW on OTC
Shares outstanding: 230,209,400
SEC-reported price per share: $0.01

Key facts

SMNRW - Semnur Pharmaceuticals, Inc. - Common Stock, par value $0.0001 is tracked under CUSIP 81686G113.
Latest finished 13F holder period is not available.
1 significant owner is listed from Schedule 13D/13G reporting.

Change

Quarterly ownership records are not available yet for this CUSIP.
This page updates as SEC-backed holdings history becomes available.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

81686G113

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

SMNRW full holder history Semnur Pharmaceuticals, Inc. SEC filings Semnur Pharmaceuticals, Inc. company facts Semnur Pharmaceuticals, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows

Security

SMNRW

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Scilex Holding Co	79%	-3.9%	$1,815,201	-$70,347	181,520,112	-3.7%	Scilex Holding Company	15 Jun 2026